Hongqiong Yang

Jiangsu Key Laboratory For Functional Substance Of Chinese Medicine, Nanjing 210023, PR China
Puerto Rico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Rhoifolin Alleviates Ulcerative Colitis by Targeting NMNAT1 and Activating SIRT1-FOXO1 Signaling to Enhance ILC3s Effector Function.

Rhoifolin Alleviates Ulcerative Colitis by Targeting NMNAT1 and Activating SIRT1-FOXO1 Signaling to Enhance ILC3s Effector Function.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 29, 2025

Immunometabolic control of ILC3s: implications for epithelial barrier homeostasis and inflammation.

Immunometabolic control of ILC3s: implications for epithelial barrier homeostasis and inflammation.

Journal: Biochemical pharmacology

Published: October 11, 2025

Zhilining formula alleviates ulcerative colitis by restricting STAT3 activation and subsequent Th17 cell differentiation.

Zhilining formula alleviates ulcerative colitis by restricting STAT3 activation and subsequent Th17 cell differentiation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: August 19, 2025

Prunus mume derived extracellular vesicle-like particles alleviate experimental colitis via disrupting NEK7-NLRP3 interaction and inflammasome activation.

Prunus mume derived extracellular vesicle-like particles alleviate experimental colitis via disrupting NEK7-NLRP3 interaction and inflammasome activation.

Journal: Journal of nanobiotechnology

Published: February 05, 2025

Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy.

Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy.

Journal: Journal of medicinal chemistry

Published: April 09, 2024

CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer.

CSF1R inhibition reprograms tumor-associated macrophages to potentiate anti-PD-1 therapy efficacy against colorectal cancer.

Journal: Pharmacological research

Published: December 01, 2023

Didymin ameliorates ulcerative colitis-associated secondary liver damage by facilitating Notch1 degradation.

Didymin ameliorates ulcerative colitis-associated secondary liver damage by facilitating Notch1 degradation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 05, 2023

Discovery of Novel Sesquiterpene Lactone Derivatives as Potent PKM2 Activators for the Treatment of Ulcerative Colitis.

Discovery of Novel Sesquiterpene Lactone Derivatives as Potent PKM2 Activators for the Treatment of Ulcerative Colitis.

Journal: Journal of medicinal chemistry

Published: April 05, 2023

Showing 1-8 of 8

Last Updated: 09/26/2026